Incidence and Outcome of Breast Biopsy Procedures During Follow-up After Treatment for Breast Cancer
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Surgery"
DOI: 10.1001/jamasurg.2017.5572
Abstract: Importance No comprehensive data are available regarding the frequency of breast biopsies performed during follow-up of treatment for invasive breast cancer. Objective To determine how often patients treated for breast cancer require breast biopsies during… read more here.
Keywords: commercial insurance; seer medicare; breast; breast cancer ... See more keywords
Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER‐medicare analysis
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Medicine"
DOI: 10.1002/cam4.1246
Abstract: Outcomes have improved considerably in multiple myeloma (MM), but disparities among racial‐ethnic groups exist. Differences in utilization of novel therapeutics are likely contributing factors. We explored such differences from the SEER‐Medicare database. A utilization analysis… read more here.
Keywords: utilization; use; analysis; seer medicare ... See more keywords
Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front‐line regimens using the SEER‐Medicare data
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2698
Abstract: The landscape of treatment for multiple myeloma (MM) has significantly changed over the last decade due to novel agents that have shown superiority in efficacy such as proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs) over… read more here.
Keywords: systemic therapies; utilization; medicare data; seer medicare ... See more keywords
Appendiceal cancer masked as inflammatory appendicitis in the elderly, not an uncommon presentation (Surveillance Epidemiology and End Results (SEER)‐Medicare Analysis)
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25641
Abstract: The misdiagnosis of appendiceal cancer as inflammatory appendicitis is becoming of greater clinical concern because of the rise of nonoperative management especially in the elder population. To quantify this rate of misdiagnosis, we retrospectively reviewed… read more here.
Keywords: inflammatory appendicitis; epidemiology; seer medicare; appendiceal cancer ... See more keywords
Malignant pleural mesothelioma characteristics and outcomes: A SEER-Medicare analysis.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of surgical oncology"
DOI: 10.1002/jso.27243
Abstract: BACKGROUND Pleural mesothelioma is rare cancer linked to asbestos exposure. Previous research has indicated that female individuals have better survival than male individuals, but this has never been examined in the Surveillance, Epidemiology, and End… read more here.
Keywords: malignant pleural; seer medicare; pleural mesothelioma; analysis ... See more keywords
Cost and Complications of Local Therapies for Early-Stage Breast Cancer
Sign Up to like & getrecommendations! Published in 2017 at "Journal Of The National Cancer Institute"
DOI: 10.1093/jnci/djw178
Abstract: Background: Guideline-concordant local therapy options for early breast cancer include lumpectomy plus whole breast irradiation (Lump+WBI), lumpectomy plus brachytherapy, mastectomy alone, mastectomy plus reconstruction, and, in older women, lumpectomy alone. We performed a comparative examination… read more here.
Keywords: cost complications; lump wbi; seer medicare; breast cancer ... See more keywords
Trends and outcomes of early and late palliative care consultation for adult patients with glioblastoma: A SEER-Medicare retrospective study.
Sign Up to like & getrecommendations! Published in 2022 at "Neuro-oncology practice"
DOI: 10.1093/nop/npac026
Abstract: Background Glioblastoma (GBM) carries a poor prognosis despite standard of care. Early palliative care (PC) has been shown to enhance survival and quality of life while reducing healthcare costs for other cancers. This study investigates… read more here.
Keywords: seer medicare; care; consultation; palliative care ... See more keywords
Death certificates compared to SEER‐Medicare data for surveillance of liver cancer mortality due to hepatitis B or hepatitis C infection
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13498
Abstract: Hepatocellular carcinoma (HCC) is often caused by hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. To investigate the completeness of death certificates for recording viral hepatitis in HCC death, we compared the proportion… read more here.
Keywords: death; surveillance; hepatitis; infection ... See more keywords
Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis.
Sign Up to like & getrecommendations! Published in 2017 at "Cancer research"
DOI: 10.1158/0008-5472.can-17-0687
Abstract: The widely prescribed diabetes medicine metformin has been reported to lower the risk of incident breast cancer, but it is unclear whether it affects malignant progression after diagnosis. In this study, we conducted a retrospective… read more here.
Keywords: stage breast; seer medicare; breast cancer; cancer ... See more keywords
Adherence to Lenalidomide in Older Patients with Multiple Myeloma (MM): A SEER-Medicare Analysis
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.3432.3432
Abstract: Introduction: Lenalidomide (Len) is an effective, convenient orally-administered therapeutic option for older adults with MM. In one recent survey of 64 patients (pts) with MM on oral therapy, 92% of respondents self-reported taking every dose… read more here.
Keywords: day; honoraria; seer medicare; adherence ... See more keywords
Real-world effectiveness of approved anticancer agents among Medicare beneficiaries.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.6589
Abstract: 6589 Background: The overall survival (OS) among elderly patients (pts) treated with novel anticancer agents in the real world may be inferior to the OS reported in pivotal trials for drug approval. Pts ≥ 65… read more here.
Keywords: medicare pts; cancer; among medicare; trial ... See more keywords